Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitors
Leukemia Research, 06/21/2012
Clinical Article
Pullarkat V et al. – The authors conclude that exposure to deferasirox (DFX) results in dose–dependent inhibition of proliferation, and survival in MDS progenitors.



